Tessera Therapeutics

Tessera Therapeutics is focused on advancing TSRA-196 through carefully designed clinical studies to evaluate its safety and potential benefit.

At this time, Tessera does not offer expanded access to TSRA-196 outside of clinical trials. TSRA-196 is in early clinical development, and we believe participation in a clinical study is the most appropriate way for patients to access this investigational therapy while ensuring appropriate safety monitoring and data collection.

Patients and healthcare providers interested in TSRA-196 are encouraged to visit ClinicalTrials.gov and other global clinical trial registers to learn more about ongoing or future clinical studies. 

This policy may be updated as development of TSRA-196 progresses.